Immunotherapy improves long-term overall survival in patients with advanced melanoma, according to the results of a...

The European Society for Medical Oncology (ESMO) Congress 2024, which took place from 13-17 September in...

New Irish research has revealed the first-ever national data on the incidence of sudden unexpected death...

New research presented at ECTRIMS 2024 suggests that initiating monoclonal antibody therapy during childhood, rather than...

 A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new...

A pioneering study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening...

A new study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS),...

Rheumatologists need to be more aware of the potential contribution of immune checkpoint inhibitors (ICI) in...

The refinement of surgical techniques and improved technology in recent years means modern hand surgery can...

Although rare, systemic sclerosis has a significant impact and requires a personalised approach to optimise outcomes...

This year’s Irish Society for Rheumatology (ISR) Autumn Meeting attracted a record number of delegates with...

The practical management of high and low immunoglobulins in the rheumatology clinic was the topic of...